SERPINE1 as an Independent Prognostic Marker and Therapeutic Target for Nicotine-Related Oral Carcinoma.

Authors:
Guo X; Sun Z; Chen H; Ling J; Zhao H and 2 more

Journal:
Clin Exp Otorhinolaryngol

Publication Year: 2022

DOI:
10.21053/ceo.2022.01480

PMCID:
PMC9985984

PMID:
36510682

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Clin Exp Otorhinolaryngol

Abbreviation: Clin Exp Otorhinolaryngol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Otorhinolaryngology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Early Postoperative Benefits in Receptive and Expressive Language Development After Cochlear Implan…
Lee SJ; Oh H; Shin KH and 11 more (2024) - Transparency Score: 3/6
Assessment of Esophageal Reconstruction via Bioreactor Cultivation of a Synthetic Scaffold in a Can…
Kim IG; Wu Y; Park SA and 6 more (2023) - Transparency Score: 3/6
Characteristics of Hearing Loss Among Older Adults in the Korean Genome and Epidemiology Study: A C…
Oh KH; Cho H; Lee SK and 2 more (2023) - Transparency Score: 3/6
Comparison between Real-Time Ultrasound-guided Percutaneous Dilatational Tracheostomy and Surgical …
Kim SY; Lee SW; Baek A and 1 more (2023) - Transparency Score: 3/6
Differences in Clinical and Immunological Characteristics According to the Various Criteria for Tis…
Yang SK; Kim JW; Won TB and 3 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"No potential conflict of interest relevant to this article was reported."

Evidence found in paper:

"This study was partially supported by the Guizhou Science and Technology Project (ZK2022-044), and the Cultivation project of Affiliated Hospital of Guizhou Medical University (I-2020-10 and gyfybsky-2021-60)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025